Yatsuji H - Search Results

1

Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: yatsuji h. Hepatology. 2007 Nov;46(5):1357-64. doi: 10.1002/hep.21836. Hepatology. 2007. PMID: 17657816

2

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholesterol levels.

Akuta N, Suzuki F, Kawamura Y, Yatsuji H, Sezaki H, Suzuki Y, Hosaka T, Kobayashi M, Kobayashi M, Arase Y, Ikeda K, Kumada H. Akuta N, et al. Among authors: yatsuji h. J Hepatol. 2007 Mar;46(3):403-10. doi: 10.1016/j.jhep.2006.09.019. Epub 2006 Nov 7. J Hepatol. 2007. PMID: 17126448 Clinical Trial.

3

Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: A preliminary report.

Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, Akuta N, Kawamura Y, Yatsuji H, Suzuki F, Suzuki Y, Arase Y, Kumada H. Torisu Y, et al. Among authors: yatsuji h. Hepatol Res. 2007 Jul;37(7):517-23. doi: 10.1111/j.1872-034X.2007.00077.x. Hepatol Res. 2007. PMID: 17539994

4

Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load.

Sezaki H, Suzuki F, Kawamura Y, Yatsuji H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Arase Y, Ikeda K, Kumada H. Sezaki H, et al. Among authors: yatsuji h. Hepatol Res. 2007 Oct;37(10):787-92. doi: 10.1111/j.1872-034X.2007.00132.x. Epub 2007 Jun 15. Hepatol Res. 2007. PMID: 17573943

5

Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2.

Hasegawa E, Kobayashi M, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kumada H. Hasegawa E, et al. Among authors: yatsuji h. Hepatol Res. 2007 Oct;37(10):793-800. doi: 10.1111/j.1872-034X.2007.00140.x. Epub 2007 Jun 25. Hepatol Res. 2007. PMID: 17593231

6

Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.

Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H. Arase Y, et al. Among authors: yatsuji h. J Med Virol. 2007 Aug;79(8):1095-102. doi: 10.1002/jmv.20866. J Med Virol. 2007. PMID: 17597485

7

Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.

Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H. Arase Y, et al. Among authors: yatsuji h. J Med Virol. 2007 Sep;79(9):1286-92. doi: 10.1002/jmv.20928. J Med Virol. 2007. PMID: 17607775

8

Serum KL-6 level is elevated in chronic hepatitis C patients with combination therapy of pegylated interferon and ribavirin.

Arase Y, Ikeda K, Suzuki Y, Kobayashi M, Suzuki F, Akuta N, Sezaki H, Hosaka T, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H. Arase Y, et al. Among authors: yatsuji h. Intern Med. 2007;46(15):1155-60. doi: 10.2169/internalmedicine.46.0150. Epub 2007 Aug 2. Intern Med. 2007. PMID: 17675762 Free article.

9

Loss of hepatitis B surface antigen from the serum of patients with chronic hepatitis treated with lamivudine.

Kobayashi M, Suzuki F, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Yatsuji H, Kobayashi M, Suzuki Y, Arase Y, Ikeda K, Watahiki S, Iwasaki S, Miyakawa Y, Kumada H. Kobayashi M, et al. Among authors: yatsuji h. J Med Virol. 2007 Oct;79(10):1472-7. doi: 10.1002/jmv.20994. J Med Virol. 2007. PMID: 17705186 Clinical Trial.

10

Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.

Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H. Arase Y, et al. Among authors: yatsuji h. J Med Virol. 2007 Oct;79(10):1485-90. doi: 10.1002/jmv.20925. J Med Virol. 2007. PMID: 17705189 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters